Metraipolis › archive › dc_640703071ea9
Assessing the risk of adverse drug events from combining aromatase inhibitors with CDK4/6 inhibitors using the FAERS and JADER databases — Europe PMC PMID:42519783
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42519783
- DOI
- 10.3389/fmed.2026.1823079
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T21:57:24.973Z
- SHA-256 of the archived text
9d5119ca7c67214997cdcf53a4df1a11c0c669a3b931647edffb0021e16fbf7b- Stable URL of this page
https://metraipolis.com/documento/dc_640703071ea9
How to cite
Assessing the risk of adverse drug events from combining aromatase inhibitors with CDK4/6 inhibitors using the FAERS and JADER databases — Europe PMC PMID:42519783 — Europe PMC (en), https://europepmc.org/article/MED/42519783 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_640703071ea9 (Metraipolis archive dc_640703071ea9, sha256 9d5119ca7c67214997cdcf53a4df1a11c0c669a3b931647edffb0021e16fbf7b)
BibTeX
@misc{dc640703071ea9,
title = {Assessing the risk of adverse drug events from combining aromatase inhibitors with CDK4/6 inhibitors using the FAERS and JADER databases — Europe PMC PMID:42519783},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42519783},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_640703071ea9; sha256 9d5119ca7c67214997cdcf53a4df1a11c0c669a3b931647edffb0021e16fbf7b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42519783. Agents can read the archived copy with the MCP tool read_document.